Pulse Biosciences, Inc Common Stock (DE)

PLSENASDAQ • USD
ThemeMedical Devices & HealthTech›Surgical & Robotic Systems
26.40 USD
↗ 0.08 (0.30%)🟢PRE MARKET (AS OF 04:00 AM EDT)
🟢Market: OPEN

Pulse Biosciences, Inc Common Stock (DE) (PLSE) trades at $26.40 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jul 15, 2026.

Open?$26.40
High?$26.40
Low?$26.40
Prev. Close?$26.32
Volume?N/A
Avg. Volume?343.5K
Bid / Ask
Bid?$22.60 × 100
Ask?$31.86 × 100
Spread?$9.26
Midpoint?$27.23
Valuation & Ratios
Market Cap?1.8B
Shares Out?69.2M
Float?18.2M
Float %?26.6%
P/E Ratio?N/A
P/B Ratio?27.48
EPS?-$1.08
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Themes
Medical Devices & HealthTech›Surgical & Robotic SystemsNanotechnology & Advanced Materials›Nanomedicine & Drug Delivery
Employees
116
Market Cap
1.8B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.pulsebiosciences.com
Listed
2016-05-18
Address
3957 POINT EDEN WAY
HAYWARD, CA 94545
Phone: 510-906-4600
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
55
Short Sent.?
25
Piotroski F-Score?0/9Weak
Altman Z-Score?60.81Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?15.72%High
Short Interest?2.9M
Days to Cover?6.6
Free Float18.2M
Avg Daily Volume433.6K
Settlement Date2026-06-30
Financial Health
Current Ratio?7.26Strong
Quick Ratio?7.24Strong
Cash Ratio?6.97Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
N/A▾
P/B?
Peers
100
S&P
3
27.48HIGH▾
P/S?
Peers
100
S&P
3
2,425.57HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-22.8CHEAP▾
EV/Sales?
Peers
100
S&P
3
2,334.59HIGH▾
Returns & Efficiency
ROE?
S&P
3
-112.5%WEAK▾
ROA?
S&P
3
-91.4%WEAK▾
Cash Flow & Enterprise
FCF?$-55499000
Enterprise Value?$1.8B
Fundamentals ratios updated end of day
MarketsMoversWatchlist